Mwandishi:
Mhariri:
Imeboershwa:
ULY CLINIC
ULY CLINIC
17 Februari 2026, 14:31:27
Atopic Eczema
Atopic eczema, also called atopic dermatitis, is a chronic, relapsing inflammatory skin disorder that occurs on a background of atopy.
There is often a personal or family history of atopic diseases such as:
Asthma
Allergic rhinitis (hay fever)
Atopic dermatitis
The disease is characterized by intense pruritus, xerosis (dry skin), and eczematous lesions that vary with age.
Eczema is often triggered or exacerbated by environmental factors, allergens, irritants, infections, or stress.
Clinical Forms and Diagnostic Criteria
Atopic eczema can present differently depending on the patient’s age and disease stage.
Infantile Eczema (“Milk Crust”)
Usually appears around 3 months of age
Lesions are oozing, crusted, and typically involve:
Cheeks
Forehead
Scalp
Important: If generalized exfoliative dermatitis develops, refer to a higher-level facility for specialist care.
Flexural Eczema
Onset around 3–4 years of age
Predominantly affects flexural surfaces:
Elbows
Knees
Nape of the neck
Features include:
Thickening and lichenification
Intense pruritus, often worse at night
Note: Eczema may evolve through three stages:
Acute – weeping lesions
Subacute – crusted lesions
Chronic – lichenified, scaly skin
Signs & Symptoms
Intense itching (pruritus)
Erythema and inflammation
Oozing or crusted lesions (in acute phase)
Lichenification and hyperpigmentation (in chronic phase)
Xerosis (dry, rough skin)
Secondary infections (bacterial, viral, or fungal)
Excoriations due to scratching
Investigations
Routine investigations are usually not required, but may be considered in complicated or atypical cases:
Skin swab for bacterial culture (if secondary infection suspected)
Patch testing for contact allergens
IgE levels in severe or atypical presentations
Skin biopsy (rarely) if diagnosis is uncertain
Treatment
Management of atopic eczema is multimodal, involving non-pharmacological and pharmacological strategies.
Non-Pharmacological Treatment
Patient Education: Explain chronic nature, triggers, and importance of adherence
Avoid Triggers:
Skin irritants (soaps, detergents, wool, harsh cleansers)
Extreme temperatures
Allergens
Emollients:
Generous use of skin moisturizers (emulsifying ointments, aqueous creams)
Bath oils or soap substitutes
Bathing Practices:
Short lukewarm baths
Avoid prolonged soaking or harsh scrubbing
Pharmacological Treatment
Antihistamines (for pruritus)
Promethazine 25 mg PO at bedtime (may increase to 50 mg if needed)
Cetirizine 10 mg PO once daily
Loratadine 10 mg PO once daily
Topical Corticosteroids
Mild lesions / delicate skin surfaces:
Hydrocortisone 1% ointment, apply 12-hourly
Moderate lesions:
Betamethasone valerate 0.025% cream/ointment, apply 12-hourly for 2 weeks
Severe or Refractory Cases
Adjunct therapies:
Sedating antihistamines
Occlusive bandaging
Short course systemic corticosteroids (e.g., Prednisolone)
Treat secondary infections (bacterial or viral) promptly
Wet (“Weepy”) Lesions
Saline or Potassium permanganate 1:4000 (0.025%) baths once daily for 2–4 days until dry
If extensive, prescribe antibiotics for 5–10 days (as for impetigo)
Chronic / Lichenified Skin
Apply emollients (emulsifying ointment or liquid paraffin)
Use the mildest effective topical steroid, applied thinly twice daily
Avoid potent steroids on facial or delicate skin
Classes of Topical Steroids
Very Potent: 0.05% Clobetasol propionate
Potent: 0.1% Betamethasone valerate
Diluted Potent: 0.025% Betamethasone valerate
Moderately Potent: 0.05% Clobetasol butyrate
Mild: 1% Hydrocortisone
Caution: Long-term or extensive use may cause:
Striae
Acne
Hyperpigmentation or hypopigmentation
Skin atrophy
Hirsutism
Patient education: Avoid use as cosmetic for skin lightening.
Prevention
Consistent use of emollients
Avoid known irritants and allergens
Maintain regular bathing and skin care routines
Early treatment of infections
Avoid scratching (use gloves for infants at night if needed)
Complications
Secondary bacterial infection (Staphylococcus aureus)
Viral infections (eczema herpeticum)
Lichenification and permanent hyperpigmentation
Sleep disturbance due to nocturnal pruritus
Prognosis
Chronic and relapsing; severity may reduce with age
Proper skin care and trigger avoidance improves quality of life
Severe cases may require specialist dermatology car
References
Tanzania Ministry of Health. Standard Treatment Guidelines & National Essential Medicines List (STG/NEMLIT). 7th ed. Dodoma: MoH; 2023.
Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2014;71(1):116–132.
Williams HC. Atopic dermatitis. N Engl J Med. 2005;352:2314–2324.
Boguniewicz M, Leung DY. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242:233–246.
World Health Organization. WHO Model Formulary 2023. Geneva: WHO; 2023.
Imeandikwa;
3 Novemba 2020, 12:19:48
